C F Perno - JoVE Visualize

Showing results (61-70 of 134) with videos related to

Pageof 14

Sort By:

Blood|March 1, 1991

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donorsL M Cummins, K J Weinhold, T J Matthews, et al.

Antiviral Research|January 1, 1994

Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonatesR Caliò, N Villani, E Balestra, et al.

Journal of Medicinal Chemistry|November 25, 1994

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.

Molecular Pharmacology|August 1, 1996

Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokinesC F Perno, E Balestra, S Aquaro, et al.

Infection|October 27, 2007

Evidence of dual sexual transmission of multi-resistant HIV with two years persistence of resistance to NRTI and NNRTI: a case reportM Zaccarelli, P Marconi, U Visco-Comandini, et al.

Molecular Pharmacology|December 16, 1997

S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivationD Daelemans, J A Esté, M Witvrouw, et al.

Blood|November 15, 1994

Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus bindingA Bergamini, C F Perno, L Dini, et al.

The Journal of Antimicrobial Chemotherapy|June 5, 2001

Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virusL Rossi, S Serafini, L Cappellacci, et al.

Antimicrobial Agents and Chemotherapy|December 22, 1999

Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophagesS Aquaro, O Wedgwood, C Yarnold, et al.

Nucleosides, Nucleotides & Nucleic Acids|December 7, 2007

Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovirP Franchetti, L Cappellacci, R Petrelli, et al.

Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:

Pageof 14

Blood|March 1, 1991

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donorsL M Cummins, K J Weinhold, T J Matthews, et al.

Antiviral Research|January 1, 1994

Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonatesR Caliò, N Villani, E Balestra, et al.

Journal of Medicinal Chemistry|November 25, 1994

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.

Molecular Pharmacology|August 1, 1996

Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokinesC F Perno, E Balestra, S Aquaro, et al.

Infection|October 27, 2007

Evidence of dual sexual transmission of multi-resistant HIV with two years persistence of resistance to NRTI and NNRTI: a case reportM Zaccarelli, P Marconi, U Visco-Comandini, et al.

Molecular Pharmacology|December 16, 1997

S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivationD Daelemans, J A Esté, M Witvrouw, et al.

Blood|November 15, 1994

Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus bindingA Bergamini, C F Perno, L Dini, et al.

The Journal of Antimicrobial Chemotherapy|June 5, 2001

Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virusL Rossi, S Serafini, L Cappellacci, et al.

Antimicrobial Agents and Chemotherapy|December 22, 1999

Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophagesS Aquaro, O Wedgwood, C Yarnold, et al.

Nucleosides, Nucleotides & Nucleic Acids|December 7, 2007

Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovirP Franchetti, L Cappellacci, R Petrelli, et al.

Pageof 14